Rank | Gene Set | Z-score |
---|---|---|
1 | angiotensin maturation (GO:0002003) | 5.90197882 |
2 | glycosphingolipid catabolic process (GO:0046479) | 5.80389781 |
3 | glycolipid catabolic process (GO:0019377) | 5.50884364 |
4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.46193482 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.19538327 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.19538327 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.19538327 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.19538327 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.19538327 |
10 | positive regulation by symbiont of host defense response (GO:0052509) | 5.19538327 |
11 | oligosaccharide catabolic process (GO:0009313) | 5.07824199 |
12 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 5.03488909 |
13 | adhesion of symbiont to host cell (GO:0044650) | 4.95121073 |
14 | virion attachment to host cell (GO:0019062) | 4.95121073 |
15 | positive regulation of antigen processing and presentation (GO:0002579) | 4.93042219 |
16 | ceramide catabolic process (GO:0046514) | 4.87481611 |
17 | neutrophil activation involved in immune response (GO:0002283) | 4.77381823 |
18 | membrane lipid catabolic process (GO:0046466) | 4.63679616 |
19 | sphingolipid catabolic process (GO:0030149) | 4.54339376 |
20 | adhesion of symbiont to host (GO:0044406) | 4.47099064 |
21 | microglial cell activation (GO:0001774) | 4.38814147 |
22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.22607073 |
23 | regulation of antigen processing and presentation (GO:0002577) | 4.17718526 |
24 | macrophage activation involved in immune response (GO:0002281) | 4.14151039 |
25 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.10250339 |
26 | transcytosis (GO:0045056) | 4.08257329 |
27 | positive regulation of interferon-alpha production (GO:0032727) | 4.03750751 |
28 | regulation of guanylate cyclase activity (GO:0031282) | 3.98966836 |
29 | NIK/NF-kappaB signaling (GO:0038061) | 3.97739089 |
30 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.95606058 |
31 | neutrophil activation (GO:0042119) | 3.94559126 |
32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.87645591 |
33 | response to host immune response (GO:0052572) | 3.87645591 |
34 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.84949218 |
35 | regulation of interferon-alpha production (GO:0032647) | 3.83581530 |
36 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.81696953 |
37 | granulocyte activation (GO:0036230) | 3.75904624 |
38 | intestinal absorption (GO:0050892) | 3.73784523 |
39 | peptide catabolic process (GO:0043171) | 3.73158368 |
40 | N-acetylneuraminate metabolic process (GO:0006054) | 3.68344645 |
41 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.62363229 |
42 | regulation of vitamin metabolic process (GO:0030656) | 3.60188031 |
43 | regulation of activation of Janus kinase activity (GO:0010533) | 3.56704325 |
44 | histamine secretion (GO:0001821) | 3.56570075 |
45 | positive regulation of interleukin-12 production (GO:0032735) | 3.56110007 |
46 | positive regulation of respiratory burst (GO:0060267) | 3.52482778 |
47 | amino sugar catabolic process (GO:0046348) | 3.51728189 |
48 | response to peptidoglycan (GO:0032494) | 3.49767314 |
49 | response to muramyl dipeptide (GO:0032495) | 3.45243133 |
50 | macrophage activation (GO:0042116) | 3.44367806 |
51 | detection of molecule of bacterial origin (GO:0032490) | 3.38669226 |
52 | myeloid dendritic cell differentiation (GO:0043011) | 3.37950517 |
53 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37168165 |
54 | response to host (GO:0075136) | 3.37168165 |
55 | response to host defenses (GO:0052200) | 3.37168165 |
56 | positive regulation of leukocyte degranulation (GO:0043302) | 3.33008428 |
57 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.32605408 |
58 | regulation of mononuclear cell migration (GO:0071675) | 3.27593293 |
59 | positive regulation of T cell migration (GO:2000406) | 3.26409739 |
60 | myeloid dendritic cell activation (GO:0001773) | 3.24144169 |
61 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.23880722 |
62 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.23514366 |
63 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.20681449 |
64 | cellular response to type I interferon (GO:0071357) | 3.17417159 |
65 | type I interferon signaling pathway (GO:0060337) | 3.17417159 |
66 | response to type I interferon (GO:0034340) | 3.17101500 |
67 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.16784805 |
68 | dendritic cell chemotaxis (GO:0002407) | 3.13326598 |
69 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.11831236 |
70 | myeloid cell activation involved in immune response (GO:0002275) | 3.09978086 |
71 | epoxygenase P450 pathway (GO:0019373) | 3.07477666 |
72 | dendritic cell differentiation (GO:0097028) | 3.06393938 |
73 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.05781343 |
74 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.04514299 |
75 | dendritic cell migration (GO:0036336) | 3.04492848 |
76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.04009077 |
77 | positive regulation of mast cell degranulation (GO:0043306) | 3.04009077 |
78 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.03079967 |
79 | regulation of interleukin-12 production (GO:0032655) | 3.03078205 |
80 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.02875148 |
81 | natural killer cell mediated immunity (GO:0002228) | 3.02875148 |
82 | positive regulation of lymphocyte migration (GO:2000403) | 3.01658125 |
83 | positive regulation of type 2 immune response (GO:0002830) | 3.01472021 |
84 | T-helper 1 type immune response (GO:0042088) | 3.01415030 |
85 | germinal center formation (GO:0002467) | 3.01377359 |
86 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.00472672 |
87 | eosinophil chemotaxis (GO:0048245) | 3.00387046 |
88 | macrophage differentiation (GO:0030225) | 3.00323367 |
89 | regulation of podosome assembly (GO:0071801) | 2.99904299 |
90 | immunoglobulin mediated immune response (GO:0016064) | 2.98620106 |
91 | fructose metabolic process (GO:0006000) | 2.98580230 |
92 | regulation of interleukin-1 secretion (GO:0050704) | 2.98449107 |
93 | I-kappaB phosphorylation (GO:0007252) | 2.97699420 |
94 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.97639990 |
95 | peptide hormone processing (GO:0016486) | 2.96869011 |
96 | adenosine receptor signaling pathway (GO:0001973) | 2.96793108 |
97 | response to hydroperoxide (GO:0033194) | 2.93635939 |
98 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.92701256 |
99 | positive regulation of interleukin-10 production (GO:0032733) | 2.91498402 |
100 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.91274203 |
101 | response to hepatocyte growth factor (GO:0035728) | 2.90171118 |
102 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.90171118 |
103 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.89920920 |
104 | regulation of RIG-I signaling pathway (GO:0039535) | 2.88287951 |
105 | cellular response to cadmium ion (GO:0071276) | 2.87805769 |
106 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.87746181 |
107 | negative regulation of interleukin-17 production (GO:0032700) | 2.86789979 |
108 | positive regulation of interferon-beta production (GO:0032728) | 2.86280539 |
109 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.85548690 |
110 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.85548690 |
111 | endocrine process (GO:0050886) | 2.85548690 |
112 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.84471422 |
113 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.83992938 |
114 | positive regulation of neutrophil migration (GO:1902624) | 2.83992938 |
115 | glycosylceramide metabolic process (GO:0006677) | 2.83313832 |
116 | negative regulation of granulocyte differentiation (GO:0030853) | 2.83145422 |
117 | myeloid leukocyte activation (GO:0002274) | 2.82747333 |
118 | superoxide anion generation (GO:0042554) | 2.80955369 |
119 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80221043 |
120 | sphingosine metabolic process (GO:0006670) | 2.79287449 |
121 | positive regulation of mast cell activation (GO:0033005) | 2.79161935 |
122 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.78846818 |
123 | regulation of cGMP biosynthetic process (GO:0030826) | 2.76013628 |
124 | vitamin D metabolic process (GO:0042359) | 2.75585782 |
125 | NADH metabolic process (GO:0006734) | 2.74968505 |
126 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.74585107 |
127 | pinocytosis (GO:0006907) | 2.73926650 |
128 | sulfate transmembrane transport (GO:1902358) | 2.73276270 |
129 | cytokine secretion (GO:0050663) | 2.73193944 |
130 | glucuronate metabolic process (GO:0019585) | 2.73113670 |
131 | uronic acid metabolic process (GO:0006063) | 2.73113670 |
132 | regulation of neutrophil chemotaxis (GO:0090022) | 2.72940490 |
133 | regulation of neutrophil migration (GO:1902622) | 2.72940490 |
134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72375260 |
135 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.71765048 |
136 | negative regulation of interleukin-12 production (GO:0032695) | 2.71503471 |
137 | G-protein coupled receptor internalization (GO:0002031) | 2.70885326 |
138 | cellular response to arsenic-containing substance (GO:0071243) | 2.70807329 |
139 | L-ascorbic acid metabolic process (GO:0019852) | 2.70644847 |
140 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.69940559 |
141 | regulation of cellular extravasation (GO:0002691) | 2.68296050 |
142 | barbed-end actin filament capping (GO:0051016) | 2.67881029 |
143 | regulation of T cell migration (GO:2000404) | 2.66835651 |
144 | lymphocyte chemotaxis (GO:0048247) | 2.66587025 |
145 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.66498714 |
146 | ruffle organization (GO:0031529) | 2.66133189 |
147 | eosinophil migration (GO:0072677) | 2.65905048 |
148 | sphingomyelin metabolic process (GO:0006684) | 2.65498411 |
149 | lipoprotein transport (GO:0042953) | 2.65152849 |
150 | histamine transport (GO:0051608) | 2.65066653 |
151 | regulation of granulocyte chemotaxis (GO:0071622) | 2.65064553 |
152 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.64950527 |
153 | diol metabolic process (GO:0034311) | 2.64848386 |
154 | regulation of systemic arterial blood pressure (GO:0003073) | 2.64465092 |
155 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.64334996 |
156 | regulation of interleukin-17 production (GO:0032660) | 2.64095501 |
157 | T-helper cell differentiation (GO:0042093) | 2.63590556 |
158 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.63590556 |
159 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.62667840 |
160 | regulation of macrophage chemotaxis (GO:0010758) | 2.62500861 |
161 | respiratory burst (GO:0045730) | 2.59919982 |
162 | positive regulation of interleukin-1 production (GO:0032732) | 2.58371811 |
163 | cellular glucuronidation (GO:0052695) | 2.57757006 |
164 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57063801 |
165 | B cell mediated immunity (GO:0019724) | 2.56727230 |
166 | regulation of respiratory burst (GO:0060263) | 2.56200127 |
167 | response to acidic pH (GO:0010447) | 2.55561230 |
168 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.55212081 |
169 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.52759139 |
170 | transepithelial transport (GO:0070633) | 2.52648640 |
171 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.51606923 |
172 | regulation of mast cell degranulation (GO:0043304) | 2.50858914 |
173 | glycoside metabolic process (GO:0016137) | 2.49870213 |
174 | vitamin biosynthetic process (GO:0009110) | 2.49156814 |
175 | regulation of intracellular pH (GO:0051453) | 2.47727671 |
176 | protein localization to endosome (GO:0036010) | 2.47391367 |
177 | regulation of cholesterol storage (GO:0010885) | 2.45730706 |
178 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.45342185 |
179 | lysosome organization (GO:0007040) | 2.43658163 |
180 | lytic vacuole organization (GO:0080171) | 2.43658163 |
181 | regulation of superoxide anion generation (GO:0032928) | 2.43185036 |
182 | oligosaccharide metabolic process (GO:0009311) | 2.43031618 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.75030440 |
2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.63529378 |
3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.19464986 |
4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.56877790 |
5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.47890641 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.38071139 |
7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.10601163 |
8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.90648758 |
9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75782677 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.74522135 |
11 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.54296928 |
12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.52055788 |
13 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.44158662 |
14 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39753708 |
15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.38194833 |
16 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.24904664 |
17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.21476942 |
18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.20195479 |
19 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10281396 |
20 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.07437618 |
21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.05845942 |
22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.99167245 |
23 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.96843961 |
24 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.96810227 |
25 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.94289158 |
26 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.89597658 |
27 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.88462759 |
28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.79000015 |
29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77450330 |
30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75838629 |
31 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.62808299 |
32 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.61730574 |
33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60750031 |
34 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57611399 |
35 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.57474309 |
36 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.55467439 |
37 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.54908959 |
38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.54649695 |
39 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.53239074 |
40 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49773964 |
41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.48057739 |
42 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.44538017 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.44264696 |
44 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.43554752 |
45 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.39575351 |
46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39254962 |
47 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.36900279 |
48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.35603066 |
49 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.35547657 |
50 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34246668 |
51 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.30919127 |
52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30803575 |
53 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.30520370 |
54 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.29479973 |
55 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27169482 |
56 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.25088650 |
57 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24650997 |
58 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24633839 |
59 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.24472798 |
60 | SPI1_23127762_ChIP-Seq_K562_Human | 1.21611526 |
61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21434155 |
62 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20613506 |
63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.20105557 |
64 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19378539 |
65 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.17901426 |
66 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.16070662 |
67 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.15965820 |
68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.14649784 |
69 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.14035633 |
70 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13200030 |
71 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12860811 |
72 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.11494812 |
73 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10112508 |
74 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.10012505 |
75 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09857056 |
76 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09538663 |
77 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09434738 |
78 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.09433341 |
79 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08959946 |
80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08669393 |
81 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.08515403 |
82 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08479913 |
83 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08312307 |
84 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.07781893 |
85 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.07421662 |
86 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.06940398 |
87 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06483474 |
88 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06273525 |
89 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.05855301 |
90 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.05314638 |
91 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.05304557 |
92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04724063 |
93 | * PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.03788837 |
94 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03051326 |
95 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02933284 |
96 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02859380 |
97 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01539168 |
98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00695589 |
99 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.00491836 |
100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.00316975 |
101 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00301978 |
102 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.99712884 |
103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.99618627 |
104 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99617105 |
105 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.98421920 |
106 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98037855 |
107 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97814641 |
108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.97439964 |
109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96888303 |
110 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96843259 |
111 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96266473 |
112 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.95691823 |
113 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95385135 |
114 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95299900 |
115 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.94997539 |
116 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94913682 |
117 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.94769355 |
118 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94739128 |
119 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.94683414 |
120 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94455468 |
121 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.94312059 |
122 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93831026 |
123 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.92934303 |
124 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.92786448 |
125 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92699868 |
126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92392438 |
127 | * P300_18555785_Chip-Seq_ESCs_Mouse | 0.92047249 |
128 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.90878399 |
129 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90871528 |
130 | RXR_22108803_ChIP-Seq_LS180_Human | 0.90374096 |
131 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90250531 |
132 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90250531 |
133 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.89992245 |
134 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.89340840 |
135 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.88779738 |
136 | * ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.88001278 |
137 | MYB_26560356_Chip-Seq_TH2_Human | 0.87856115 |
138 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.87690716 |
139 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87414627 |
140 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.87277041 |
141 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.86834523 |
142 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.85615899 |
143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.85245676 |
144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.84818806 |
145 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.84195149 |
146 | * CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.82996735 |
147 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.82502067 |
148 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82288910 |
149 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.81544169 |
150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81321948 |
151 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.81293196 |
152 | VDR_22108803_ChIP-Seq_LS180_Human | 0.81118258 |
153 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81037525 |
154 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80397662 |
155 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.79709694 |
156 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.79537651 |
157 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.79339532 |
158 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.79190963 |
159 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.76203561 |
160 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75783196 |
161 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.75676874 |
162 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.74408051 |
163 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73679668 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.81708362 |
2 | MP0001835_abnormal_antigen_presentation | 4.56095185 |
3 | MP0002254_reproductive_system_inflammat | 4.13829966 |
4 | MP0002148_abnormal_hypersensitivity_rea | 3.40400119 |
5 | MP0000685_abnormal_immune_system | 3.28779692 |
6 | MP0001790_abnormal_immune_system | 3.14717427 |
7 | MP0005387_immune_system_phenotype | 3.14717427 |
8 | MP0005310_abnormal_salivary_gland | 3.11712151 |
9 | MP0004510_myositis | 3.07828173 |
10 | MP0010234_abnormal_vibrissa_follicle | 3.03228848 |
11 | MP0003195_calcinosis | 3.00893521 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.95280929 |
13 | MP0000569_abnormal_digit_pigmentation | 2.92426696 |
14 | MP0005365_abnormal_bile_salt | 2.92405407 |
15 | MP0009785_altered_susceptibility_to | 2.82986618 |
16 | MP0003436_decreased_susceptibility_to | 2.76267281 |
17 | MP0005671_abnormal_response_to | 2.75218467 |
18 | MP0002419_abnormal_innate_immunity | 2.66830308 |
19 | MP0005360_urolithiasis | 2.66368849 |
20 | MP0001346_abnormal_lacrimal_gland | 2.60287564 |
21 | MP0005000_abnormal_immune_tolerance | 2.59918122 |
22 | MP0006082_CNS_inflammation | 2.58346082 |
23 | MP0003172_abnormal_lysosome_physiology | 2.41242068 |
24 | MP0002452_abnormal_antigen_presenting | 2.37494842 |
25 | MP0001800_abnormal_humoral_immune | 2.37380898 |
26 | MP0005025_abnormal_response_to | 2.28504102 |
27 | MP0005058_abnormal_lysosome_morphology | 2.25040890 |
28 | MP0001666_abnormal_nutrient_absorption | 2.24990337 |
29 | MP0002723_abnormal_immune_serum | 2.23867835 |
30 | MP0005257_abnormal_intraocular_pressure | 2.23759028 |
31 | * MP0002277_abnormal_respiratory_mucosa | 2.11344583 |
32 | MP0005085_abnormal_gallbladder_physiolo | 2.07169577 |
33 | MP0002163_abnormal_gland_morphology | 2.00232315 |
34 | MP0001819_abnormal_immune_cell | 1.98513213 |
35 | MP0004019_abnormal_vitamin_homeostasis | 1.95524066 |
36 | MP0002420_abnormal_adaptive_immunity | 1.93156953 |
37 | MP0003806_abnormal_nucleotide_metabolis | 1.87077076 |
38 | MP0001873_stomach_inflammation | 1.78989658 |
39 | MP0003303_peritoneal_inflammation | 1.78869229 |
40 | MP0003724_increased_susceptibility_to | 1.73302895 |
41 | MP0005167_abnormal_blood-brain_barrier | 1.68934025 |
42 | MP0001348_abnormal_lacrimal_gland | 1.68083986 |
43 | MP0010352_gastrointestinal_tract_polyps | 1.65787262 |
44 | MP0002166_altered_tumor_susceptibility | 1.64260883 |
45 | MP0004782_abnormal_surfactant_physiolog | 1.63044159 |
46 | MP0003300_gastrointestinal_ulcer | 1.56443720 |
47 | MP0003183_abnormal_peptide_metabolism | 1.55685444 |
48 | MP0004947_skin_inflammation | 1.55543100 |
49 | MP0004264_abnormal_extraembryonic_tissu | 1.51865592 |
50 | MP0002405_respiratory_system_inflammati | 1.51217253 |
51 | MP0001845_abnormal_inflammatory_respons | 1.51177514 |
52 | MP0005379_endocrine/exocrine_gland_phen | 1.50482846 |
53 | MP0003191_abnormal_cellular_cholesterol | 1.50395534 |
54 | MP0005464_abnormal_platelet_physiology | 1.48555117 |
55 | MP0001853_heart_inflammation | 1.47620488 |
56 | MP0006054_spinal_hemorrhage | 1.46436407 |
57 | MP0002006_tumorigenesis | 1.44471348 |
58 | MP0010155_abnormal_intestine_physiology | 1.40787621 |
59 | * MP0001533_abnormal_skeleton_physiology | 1.40222164 |
60 | * MP0000716_abnormal_immune_system | 1.34200517 |
61 | MP0005645_abnormal_hypothalamus_physiol | 1.34166952 |
62 | MP0003448_altered_tumor_morphology | 1.30462600 |
63 | * MP0002998_abnormal_bone_remodeling | 1.29246373 |
64 | MP0009764_decreased_sensitivity_to | 1.28079489 |
65 | MP0003045_fibrosis | 1.27333981 |
66 | MP0005165_increased_susceptibility_to | 1.25580568 |
67 | MP0002009_preneoplasia | 1.25332398 |
68 | MP0010386_abnormal_urinary_bladder | 1.23333416 |
69 | MP0004043_abnormal_pH_regulation | 1.22901276 |
70 | MP0009643_abnormal_urine_homeostasis | 1.21373560 |
71 | MP0001851_eye_inflammation | 1.21367208 |
72 | MP0008004_abnormal_stomach_pH | 1.18022186 |
73 | MP0003828_pulmonary_edema | 1.17632111 |
74 | MP0005174_abnormal_tail_pigmentation | 1.16931542 |
75 | MP0008469_abnormal_protein_level | 1.12296511 |
76 | * MP0002398_abnormal_bone_marrow | 1.10547012 |
77 | MP0005451_abnormal_body_composition | 1.09055484 |
78 | MP0000015_abnormal_ear_pigmentation | 1.07710795 |
79 | MP0002876_abnormal_thyroid_physiology | 1.05309232 |
80 | MP0005332_abnormal_amino_acid | 1.01571795 |
81 | MP0005319_abnormal_enzyme/_coenzyme | 1.00749737 |
82 | MP0001986_abnormal_taste_sensitivity | 0.99790008 |
83 | MP0001664_abnormal_digestion | 0.99415712 |
84 | MP0001727_abnormal_embryo_implantation | 0.99318812 |
85 | MP0005381_digestive/alimentary_phenotyp | 0.95928055 |
86 | MP0010329_abnormal_lipoprotein_level | 0.95187615 |
87 | MP0001765_abnormal_ion_homeostasis | 0.95036702 |
88 | MP0002136_abnormal_kidney_physiology | 0.94838771 |
89 | MP0000609_abnormal_liver_physiology | 0.94675198 |
90 | MP0005636_abnormal_mineral_homeostasis | 0.94490060 |
91 | * MP0002429_abnormal_blood_cell | 0.94428280 |
92 | MP0001764_abnormal_homeostasis | 0.93430767 |
93 | MP0000858_altered_metastatic_potential | 0.92976910 |
94 | MP0001756_abnormal_urination | 0.92176402 |
95 | MP0003868_abnormal_feces_composition | 0.91161953 |
96 | MP0000477_abnormal_intestine_morphology | 0.90521223 |
97 | MP0003866_abnormal_defecation | 0.90453057 |
98 | MP0004147_increased_porphyrin_level | 0.89664347 |
99 | MP0002837_dystrophic_cardiac_calcinosis | 0.87555436 |
100 | MP0003941_abnormal_skin_development | 0.86567305 |
101 | MP0000383_abnormal_hair_follicle | 0.85948362 |
102 | MP0003453_abnormal_keratinocyte_physiol | 0.85783479 |
103 | MP0002693_abnormal_pancreas_physiology | 0.85096785 |
104 | MP0003690_abnormal_glial_cell | 0.84215542 |
105 | MP0003075_altered_response_to | 0.84012778 |
106 | MP0002118_abnormal_lipid_homeostasis | 0.83641316 |
107 | MP0000566_synostosis | 0.79272753 |
108 | MP0010307_abnormal_tumor_latency | 0.76778055 |
109 | MP0009840_abnormal_foam_cell | 0.76706202 |
110 | MP0005647_abnormal_sex_gland | 0.75313894 |
111 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75299133 |
112 | * MP0002722_abnormal_immune_system | 0.75293403 |
113 | * MP0000689_abnormal_spleen_morphology | 0.74616591 |
114 | MP0009333_abnormal_splenocyte_physiolog | 0.74556260 |
115 | MP0005397_hematopoietic_system_phenotyp | 0.74338012 |
116 | MP0001545_abnormal_hematopoietic_system | 0.74338012 |
117 | MP0003252_abnormal_bile_duct | 0.74268387 |
118 | MP0002796_impaired_skin_barrier | 0.72600594 |
119 | MP0000343_altered_response_to | 0.71419190 |
120 | MP0002928_abnormal_bile_duct | 0.71224334 |
121 | MP0003763_abnormal_thymus_physiology | 0.70727443 |
122 | MP0000604_amyloidosis | 0.70024433 |
123 | * MP0005390_skeleton_phenotype | 0.69450093 |
124 | MP0010678_abnormal_skin_adnexa | 0.68986509 |
125 | MP0008260_abnormal_autophagy | 0.68642138 |
126 | MP0005076_abnormal_cell_differentiation | 0.67664157 |
127 | * MP0001881_abnormal_mammary_gland | 0.66676973 |
128 | MP0003091_abnormal_cell_migration | 0.66578974 |
129 | MP0005166_decreased_susceptibility_to | 0.65273245 |
130 | MP0003879_abnormal_hair_cell | 0.65251527 |
131 | MP0000538_abnormal_urinary_bladder | 0.65220038 |
132 | MP0003566_abnormal_cell_adhesion | 0.64856326 |
133 | MP0000767_abnormal_smooth_muscle | 0.64366765 |
134 | MP0001663_abnormal_digestive_system | 0.64366525 |
135 | MP0000470_abnormal_stomach_morphology | 0.63461517 |
136 | MP0000371_diluted_coat_color | 0.63390729 |
137 | MP0002933_joint_inflammation | 0.63370749 |
138 | * MP0003795_abnormal_bone_structure | 0.63244619 |
139 | MP0005197_abnormal_uvea_morphology | 0.58794605 |
140 | MP0002098_abnormal_vibrissa_morphology | 0.58741997 |
141 | MP0000490_abnormal_crypts_of | 0.57747473 |
142 | MP0009278_abnormal_bone_marrow | 0.57180697 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.58465698 |
2 | Eczematoid dermatitis (HP:0000976) | 5.54958673 |
3 | Recurrent bacterial skin infections (HP:0005406) | 5.32033408 |
4 | Prostate neoplasm (HP:0100787) | 4.67602267 |
5 | Retrobulbar optic neuritis (HP:0100654) | 4.28306164 |
6 | Optic neuritis (HP:0100653) | 4.28306164 |
7 | Systemic lupus erythematosus (HP:0002725) | 4.22322624 |
8 | Abnormality of macrophages (HP:0004311) | 4.04920246 |
9 | Orchitis (HP:0100796) | 4.00168024 |
10 | Malnutrition (HP:0004395) | 3.98876907 |
11 | Myositis (HP:0100614) | 3.84656554 |
12 | Loss of speech (HP:0002371) | 3.81473473 |
13 | Recurrent fungal infections (HP:0002841) | 3.78631316 |
14 | Recurrent skin infections (HP:0001581) | 3.62130769 |
15 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.58169542 |
16 | Recurrent cutaneous fungal infections (HP:0011370) | 3.58169542 |
17 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47298872 |
18 | Vacuolated lymphocytes (HP:0001922) | 3.46474974 |
19 | Mutism (HP:0002300) | 3.42494157 |
20 | Gingivitis (HP:0000230) | 3.39809674 |
21 | Chronic diarrhea (HP:0002028) | 3.39775208 |
22 | * Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.38520079 |
23 | Mediastinal lymphadenopathy (HP:0100721) | 3.31612459 |
24 | Thick nail (HP:0001805) | 3.27461265 |
25 | Symptomatic seizures (HP:0011145) | 3.18820058 |
26 | Spontaneous hematomas (HP:0007420) | 3.18313306 |
27 | Metaphyseal irregularity (HP:0003025) | 3.04358766 |
28 | Abnormality of glycolipid metabolism (HP:0010969) | 3.02846798 |
29 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.02846798 |
30 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.02846798 |
31 | Agnosia (HP:0010524) | 3.01852592 |
32 | Obstructive lung disease (HP:0006536) | 2.96563691 |
33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.96563691 |
34 | Vasculitis (HP:0002633) | 2.94073154 |
35 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.90647511 |
36 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.90647511 |
37 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.90647511 |
38 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.86153075 |
39 | Increased cerebral lipofuscin (HP:0011813) | 2.84883793 |
40 | Periodontitis (HP:0000704) | 2.83921735 |
41 | Autoimmune thrombocytopenia (HP:0001973) | 2.81057598 |
42 | Dysostosis multiplex (HP:0000943) | 2.80475619 |
43 | Keratoconjunctivitis (HP:0001096) | 2.80132541 |
44 | Complement deficiency (HP:0004431) | 2.79620638 |
45 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.79216533 |
46 | Axonal loss (HP:0003447) | 2.78352725 |
47 | Nuclear cataract (HP:0100018) | 2.75411438 |
48 | Premature loss of primary teeth (HP:0006323) | 2.74335482 |
49 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.72786955 |
50 | Mucopolysacchariduria (HP:0008155) | 2.72786955 |
51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.70962687 |
52 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.70539477 |
53 | Aplasia cutis congenita (HP:0001057) | 2.65200458 |
54 | Basal ganglia calcification (HP:0002135) | 2.64182422 |
55 | Lip pit (HP:0100267) | 2.63602361 |
56 | Glomerulonephritis (HP:0000099) | 2.62575388 |
57 | Decreased circulating renin level (HP:0003351) | 2.61826552 |
58 | Eosinophilia (HP:0001880) | 2.61194600 |
59 | Upper motor neuron abnormality (HP:0002127) | 2.60905126 |
60 | Cheilitis (HP:0100825) | 2.60735249 |
61 | Inappropriate behavior (HP:0000719) | 2.59665669 |
62 | Pulmonary infiltrates (HP:0002113) | 2.55044467 |
63 | Arterial thrombosis (HP:0004420) | 2.54934914 |
64 | Recurrent viral infections (HP:0004429) | 2.54855599 |
65 | Hyperactive renin-angiotensin system (HP:0000841) | 2.53395025 |
66 | Fat malabsorption (HP:0002630) | 2.51437965 |
67 | Myocardial infarction (HP:0001658) | 2.51327556 |
68 | Hypoglycemic seizures (HP:0002173) | 2.49956252 |
69 | Increased IgM level (HP:0003496) | 2.48975508 |
70 | Abnormality of complement system (HP:0005339) | 2.48043073 |
71 | Disinhibition (HP:0000734) | 2.43739671 |
72 | Intrahepatic cholestasis (HP:0001406) | 2.42795300 |
73 | Increased IgE level (HP:0003212) | 2.40532768 |
74 | Abnormality of chloride homeostasis (HP:0011422) | 2.40293433 |
75 | Pustule (HP:0200039) | 2.38213457 |
76 | * Hydroxyprolinuria (HP:0003080) | 2.36779917 |
77 | * Abnormality of proline metabolism (HP:0010907) | 2.36779917 |
78 | Anhidrosis (HP:0000970) | 2.32055380 |
79 | Abdominal distention (HP:0003270) | 2.30641004 |
80 | Keratoconjunctivitis sicca (HP:0001097) | 2.30330768 |
81 | Hematochezia (HP:0002573) | 2.27464074 |
82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.27340004 |
83 | Abnormality of renin-angiotensin system (HP:0000847) | 2.26699207 |
84 | Hypoglycemic coma (HP:0001325) | 2.26224883 |
85 | Protuberant abdomen (HP:0001538) | 2.23837230 |
86 | Nausea (HP:0002018) | 2.23719700 |
87 | Abnormality of the prostate (HP:0008775) | 2.19352453 |
88 | * Bone pain (HP:0002653) | 2.18702464 |
89 | Bone cyst (HP:0012062) | 2.18478244 |
90 | Cardiomegaly (HP:0001640) | 2.18167000 |
91 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.16865294 |
92 | Personality changes (HP:0000751) | 2.16705104 |
93 | Metabolic alkalosis (HP:0200114) | 2.16504556 |
94 | Hypophosphatemia (HP:0002148) | 2.16387809 |
95 | Xanthomatosis (HP:0000991) | 2.16105731 |
96 | Osteomyelitis (HP:0002754) | 2.15835345 |
97 | Abnormality of the basal ganglia (HP:0002134) | 2.15481471 |
98 | Ileus (HP:0002595) | 2.15242433 |
99 | Meningitis (HP:0001287) | 2.13051819 |
100 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.12838069 |
101 | Abnormality of vitamin B metabolism (HP:0004340) | 2.12649968 |
102 | Inflammation of the large intestine (HP:0002037) | 2.12216439 |
103 | Stomatitis (HP:0010280) | 2.12017279 |
104 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.11208141 |
105 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.10239957 |
106 | Colitis (HP:0002583) | 2.09970261 |
107 | Progressive neurologic deterioration (HP:0002344) | 2.09767023 |
108 | Hypergammaglobulinemia (HP:0010702) | 2.09051589 |
109 | Leukocytosis (HP:0001974) | 2.08719439 |
110 | Granulocytopenia (HP:0001913) | 2.07938045 |
111 | Hemoptysis (HP:0002105) | 2.06284860 |
112 | Alveolar cell carcinoma (HP:0006519) | 2.03737804 |
113 | Chronic otitis media (HP:0000389) | 2.02922145 |
114 | Urticaria (HP:0001025) | 2.01205009 |
115 | Hyperphosphatemia (HP:0002905) | 2.01016460 |
116 | Petechiae (HP:0000967) | 2.00616765 |
117 | Prolonged neonatal jaundice (HP:0006579) | 1.97883803 |
118 | Gingival bleeding (HP:0000225) | 1.96905975 |
119 | Dementia (HP:0000726) | 1.95040968 |
120 | Peripheral demyelination (HP:0011096) | 1.92870529 |
121 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.92710438 |
122 | Abnormality of the nasal septum (HP:0000419) | 1.92270983 |
123 | Steatorrhea (HP:0002570) | 1.91013768 |
124 | Congenital sensorineural hearing impairment (HP:0008527) | 1.90957596 |
125 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.90305401 |
126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89971714 |
127 | Osteolytic defects of the hand bones (HP:0009699) | 1.89971714 |
128 | Cerebral hemorrhage (HP:0001342) | 1.89426641 |
129 | Agammaglobulinemia (HP:0004432) | 1.88535578 |
130 | Conjunctival telangiectasia (HP:0000524) | 1.88373400 |
131 | * Recurrent pneumonia (HP:0006532) | 1.87836160 |
132 | Apathy (HP:0000741) | 1.87759188 |
133 | Abnormality of eosinophils (HP:0001879) | 1.87699256 |
134 | Autoimmune hemolytic anemia (HP:0001890) | 1.85290372 |
135 | Keratitis (HP:0000491) | 1.84688413 |
136 | Pigmentary retinal degeneration (HP:0001146) | 1.84651523 |
137 | Multiple enchondromatosis (HP:0005701) | 1.84605705 |
138 | Abnormality of urine glucose concentration (HP:0011016) | 1.84598350 |
139 | Glycosuria (HP:0003076) | 1.84598350 |
140 | Submucous cleft hard palate (HP:0000176) | 1.84103883 |
141 | Nephritis (HP:0000123) | 1.84028203 |
142 | Parakeratosis (HP:0001036) | 1.83754430 |
143 | Chromsome breakage (HP:0040012) | 1.83249545 |
144 | Oligodontia (HP:0000677) | 1.83134095 |
145 | Villous atrophy (HP:0011473) | 1.82989304 |
146 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.82989304 |
147 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81527789 |
148 | Widely patent fontanelles and sutures (HP:0004492) | 1.80191331 |
149 | Neurofibrillary tangles (HP:0002185) | 1.79397730 |
150 | Late onset (HP:0003584) | 1.78834052 |
151 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.78644783 |
152 | Hip dysplasia (HP:0001385) | 1.78448248 |
153 | Stomach cancer (HP:0012126) | 1.78386551 |
154 | Abnormality of vitamin metabolism (HP:0100508) | 1.78344696 |
155 | Large eyes (HP:0001090) | 1.76319703 |
156 | Esophageal varix (HP:0002040) | 1.75703922 |
157 | Thin bony cortex (HP:0002753) | 1.75590934 |
158 | Neuronal loss in central nervous system (HP:0002529) | 1.75527998 |
159 | Cellulitis (HP:0100658) | 1.75128420 |
160 | Gastrointestinal inflammation (HP:0004386) | 1.74223043 |
161 | Increased CSF protein (HP:0002922) | 1.74100643 |
162 | Diminished motivation (HP:0000745) | 1.74015409 |
163 | Urethral obstruction (HP:0000796) | 1.73908481 |
164 | Ectropion (HP:0000656) | 1.73067240 |
165 | Retinal atrophy (HP:0001105) | 1.72673627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 6.52743818 |
2 | MAP3K14 | 5.37078976 |
3 | NME2 | 3.15648983 |
4 | TYK2 | 3.07541806 |
5 | IRAK4 | 2.93767172 |
6 | MST1R | 2.83991422 |
7 | SIK3 | 2.78334654 |
8 | MAP3K13 | 2.71964680 |
9 | IKBKB | 2.61908907 |
10 | IRAK3 | 2.53331042 |
11 | TGFBR2 | 2.47920146 |
12 | ERN1 | 2.39895363 |
13 | BLK | 2.37405204 |
14 | TBK1 | 2.36526189 |
15 | EPHA2 | 2.33165744 |
16 | IKBKE | 2.24688000 |
17 | PRKG2 | 2.23496911 |
18 | RIPK4 | 2.22300479 |
19 | LMTK2 | 2.20202617 |
20 | CHUK | 2.14233632 |
21 | JAK1 | 2.12424843 |
22 | JAK3 | 2.09889784 |
23 | CAMKK2 | 2.05530939 |
24 | GRK7 | 1.92793275 |
25 | STK24 | 1.92048284 |
26 | INSRR | 1.89823836 |
27 | SIK2 | 1.83268017 |
28 | TESK2 | 1.79997064 |
29 | BMPR2 | 1.79447185 |
30 | KIT | 1.72408459 |
31 | TAOK3 | 1.71186375 |
32 | TXK | 1.69389167 |
33 | EIF2AK2 | 1.66014470 |
34 | RIPK1 | 1.64106447 |
35 | EPHA3 | 1.56027463 |
36 | NUAK1 | 1.48563053 |
37 | FRK | 1.48478851 |
38 | DDR2 | 1.41021787 |
39 | EPHB1 | 1.40623027 |
40 | MAP3K11 | 1.40057742 |
41 | CAMK1D | 1.39024907 |
42 | PAK4 | 1.37670734 |
43 | TNIK | 1.34961072 |
44 | BMPR1B | 1.34445158 |
45 | TAOK1 | 1.32945510 |
46 | MAP3K12 | 1.31045004 |
47 | CDK12 | 1.30045859 |
48 | PDK2 | 1.30002995 |
49 | NEK9 | 1.28256856 |
50 | MAP3K1 | 1.26807798 |
51 | ABL2 | 1.25134319 |
52 | ADRBK2 | 1.18940769 |
53 | OXSR1 | 1.16065153 |
54 | ITK | 1.13166325 |
55 | TEC | 1.10083447 |
56 | TESK1 | 1.09311857 |
57 | MAPK15 | 1.08505447 |
58 | ZAK | 1.08367705 |
59 | CDK8 | 1.07127717 |
60 | STK16 | 1.03069966 |
61 | SYK | 1.02419326 |
62 | KDR | 1.01562295 |
63 | CDC42BPA | 1.00987246 |
64 | TGFBR1 | 1.00599783 |
65 | CSF1R | 1.00222795 |
66 | PKN1 | 0.99678099 |
67 | PIM2 | 0.98377908 |
68 | SIK1 | 0.97615940 |
69 | MARK3 | 0.96440891 |
70 | HCK | 0.95918001 |
71 | MAP3K3 | 0.95146539 |
72 | IRAK1 | 0.91937160 |
73 | PRKAA2 | 0.90294040 |
74 | STK39 | 0.90210283 |
75 | EIF2AK3 | 0.89133666 |
76 | CAMK1G | 0.88972213 |
77 | YES1 | 0.88941954 |
78 | LCK | 0.88409301 |
79 | MST4 | 0.88130019 |
80 | MAP2K6 | 0.87996988 |
81 | TAOK2 | 0.87481047 |
82 | EPHB2 | 0.87195627 |
83 | CSK | 0.85954995 |
84 | MAP3K10 | 0.85327673 |
85 | RPS6KA4 | 0.84508263 |
86 | MAP3K2 | 0.83567251 |
87 | LYN | 0.81494012 |
88 | JAK2 | 0.81427123 |
89 | FER | 0.79683100 |
90 | CDK3 | 0.79506666 |
91 | FGR | 0.79180270 |
92 | BTK | 0.73742225 |
93 | TIE1 | 0.71043144 |
94 | FGFR3 | 0.70746943 |
95 | MAPKAPK2 | 0.66642579 |
96 | TRPM7 | 0.65872610 |
97 | MAP3K8 | 0.64341070 |
98 | MATK | 0.63108711 |
99 | IRAK2 | 0.61223463 |
100 | STK3 | 0.60996733 |
101 | PTK6 | 0.59585265 |
102 | BRSK2 | 0.57413907 |
103 | PRKCE | 0.56651393 |
104 | ZAP70 | 0.55742642 |
105 | PIM1 | 0.55476653 |
106 | PRKCQ | 0.54809555 |
107 | PRKCD | 0.53500085 |
108 | FGFR4 | 0.53185916 |
109 | CASK | 0.52045619 |
110 | MAP4K1 | 0.50789366 |
111 | NLK | 0.50278659 |
112 | WNK1 | 0.50080429 |
113 | ERBB4 | 0.49422377 |
114 | DMPK | 0.49072466 |
115 | CDK6 | 0.48588455 |
116 | PDPK1 | 0.47782637 |
117 | PIK3CA | 0.47584313 |
118 | ERBB3 | 0.46850162 |
119 | SGK2 | 0.46595186 |
120 | FES | 0.46566694 |
121 | STK10 | 0.46368400 |
122 | RPS6KA5 | 0.45103457 |
123 | PIK3CG | 0.45080731 |
124 | SGK1 | 0.44627892 |
125 | STK4 | 0.41901395 |
126 | MELK | 0.41234233 |
127 | GRK1 | 0.41174193 |
128 | ABL1 | 0.40310286 |
129 | HIPK2 | 0.38762835 |
130 | CLK1 | 0.37903542 |
131 | EGFR | 0.37869986 |
132 | DAPK2 | 0.37178090 |
133 | IGF1R | 0.37153994 |
134 | PDK1 | 0.36358676 |
135 | ALK | 0.35080092 |
136 | MAPKAPK3 | 0.33373983 |
137 | TAF1 | 0.33348092 |
138 | SGK3 | 0.32850478 |
139 | LIMK1 | 0.32319018 |
140 | PLK2 | 0.31415290 |
141 | CDK9 | 0.30996155 |
142 | PBK | 0.29488867 |
143 | MET | 0.28730487 |
144 | LATS1 | 0.27963337 |
145 | GRK5 | 0.26370708 |
146 | PRKCA | 0.25516345 |
147 | INSR | 0.25382406 |
148 | MAP2K2 | 0.24587910 |
149 | MOS | 0.23913539 |
150 | DAPK1 | 0.23486351 |
151 | MAP3K9 | 0.22359989 |
152 | BCR | 0.22110113 |
153 | SMG1 | 0.22049732 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.05536870 |
2 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.60257206 |
3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58879603 |
4 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.49958212 |
5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.43715880 |
6 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.43184899 |
7 | Allograft rejection_Homo sapiens_hsa05330 | 2.42384352 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41624661 |
9 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.29842040 |
10 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.29539718 |
11 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25743177 |
12 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.20736025 |
13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.06805378 |
14 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06147917 |
15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.05849272 |
16 | Measles_Homo sapiens_hsa05162 | 1.98466372 |
17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.94334426 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.90005829 |
19 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.89946752 |
20 | Galactose metabolism_Homo sapiens_hsa00052 | 1.86797511 |
21 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.80850495 |
22 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.80786093 |
23 | Pertussis_Homo sapiens_hsa05133 | 1.78136384 |
24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74729966 |
25 | Lysosome_Homo sapiens_hsa04142 | 1.74263640 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.74263634 |
27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.73472290 |
28 | Influenza A_Homo sapiens_hsa05164 | 1.72404061 |
29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63615854 |
30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59453764 |
31 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59373242 |
32 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.59261478 |
33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.52576775 |
34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.48617500 |
35 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.47812489 |
36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44592995 |
37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.42556397 |
38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.42414983 |
39 | Malaria_Homo sapiens_hsa05144 | 1.41646764 |
40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.41349888 |
41 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.40849971 |
42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.40005774 |
43 | Asthma_Homo sapiens_hsa05310 | 1.37868457 |
44 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.34661851 |
45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.34508796 |
46 | Apoptosis_Homo sapiens_hsa04210 | 1.34184089 |
47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.31242873 |
48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.30568581 |
49 | Legionellosis_Homo sapiens_hsa05134 | 1.29218188 |
50 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.28462122 |
51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26844622 |
52 | Phagosome_Homo sapiens_hsa04145 | 1.26612157 |
53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.25051824 |
54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.19848622 |
55 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.15346961 |
56 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14682149 |
57 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.12322910 |
58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.11391333 |
59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10467175 |
60 | Salmonella infection_Homo sapiens_hsa05132 | 1.09922482 |
61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05709460 |
62 | Hepatitis C_Homo sapiens_hsa05160 | 1.04243629 |
63 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.01646990 |
64 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00276964 |
65 | Mineral absorption_Homo sapiens_hsa04978 | 1.00069832 |
66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.99675668 |
67 | Hepatitis B_Homo sapiens_hsa05161 | 0.98676778 |
68 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97535908 |
69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.97250241 |
70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96317445 |
71 | Retinol metabolism_Homo sapiens_hsa00830 | 0.94857098 |
72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90436566 |
73 | Shigellosis_Homo sapiens_hsa05131 | 0.89472292 |
74 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89205740 |
75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.88647134 |
76 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88298275 |
77 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.84530109 |
78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82880787 |
79 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82821286 |
80 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82525058 |
81 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.82350046 |
82 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.81682630 |
83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.80174204 |
84 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77310533 |
85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75824911 |
86 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.75214579 |
87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73754492 |
88 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72124197 |
89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71698523 |
90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71415458 |
91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71118153 |
92 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.68407858 |
93 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.68216619 |
94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.65310376 |
95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64316175 |
96 | Bile secretion_Homo sapiens_hsa04976 | 0.63780940 |
97 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.62571154 |
98 | Amoebiasis_Homo sapiens_hsa05146 | 0.62489689 |
99 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60797515 |
100 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.60491703 |
101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60231387 |
102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.59310807 |
103 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58302251 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56848080 |
105 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.54343224 |
106 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53296141 |
107 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.50857223 |
108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50826759 |
109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49322918 |
110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48745102 |
111 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48369228 |
112 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47755634 |
113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.46072654 |
114 | ABC transporters_Homo sapiens_hsa02010 | 0.45859913 |
115 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45741219 |
116 | Platelet activation_Homo sapiens_hsa04611 | 0.44293705 |
117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43870123 |
118 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43816743 |
119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43361566 |
120 | Adherens junction_Homo sapiens_hsa04520 | 0.43290471 |
121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42431214 |
122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42403218 |
123 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.42045564 |
124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41735796 |
125 | Melanoma_Homo sapiens_hsa05218 | 0.38761248 |
126 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38298695 |
127 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.38154433 |
128 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.36836685 |
129 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.35845427 |
130 | Prostate cancer_Homo sapiens_hsa05215 | 0.35273511 |
131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34946661 |
132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34742755 |
133 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.33596588 |
134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33354839 |
135 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.32798070 |
136 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.32649851 |
137 | Endocytosis_Homo sapiens_hsa04144 | 0.32629007 |
138 | Renin secretion_Homo sapiens_hsa04924 | 0.32198310 |
139 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.30716098 |
140 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.30240837 |
141 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28089695 |
142 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.23378760 |
143 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.22515369 |
144 | Prion diseases_Homo sapiens_hsa05020 | 0.21284051 |
145 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.20329714 |